ICON logo
Verified via Expert Interviews

ICON: Revenue, Valuation & Competitors

ICON company overview

Ownership
Public
Employees
35,784
Investors
-
Revenue / FTE
$2••k

About

Clinical research and healthcare intelligence platform for pharmaceutical, biotechnology, medical device, and government and public health sectors to conduct clinical trials, manage regulatory submissions, and support drug and device commercialization.
Ireland
Verified via Expert Interviews

Expert Vetted Data

Public disclosures rarely capture a company's internal dynamics or the true state of its technology. Gain first-hand insight by speaking with former ICON executives.

Ownership & Key Financials

Revenue

$8•••m '••
2

Revenue / FTE

$2••k '••
2

Ownership

Public

FTEs

2
+27% CAGR
10852
2020
30835
2021
34188
2022
33622
2023
35784
2024

Legal Disclaimer

The company profiles displayed here are abridged, indicative previews of the full, proprietary data available within the Dialectica Origin Platform, derived from confidential sources and expert-vetted research. This content is the exclusive Intellectual Property (IP) of Dialectica. Your access does not grant any rights to the data. Systematic copying, scraping, crawling, indexing, or extraction, whether by manual means, automated software, bots, or Large Language Models (LLMs), is strictly prohibited and violates our Terms of Use.

This information is provided 'as is' for promotional purposes only; Dialectica disclaims all liability for its accuracy, completeness, or any reliance placed upon it.